Delta Import Export Medical Company Pharmaceutical Import Profile — Vietnam (DGFT 2022–2026)

Name: Delta Import Export Medical Company Pharmaceutical Import Records from India — 3 Products, $362.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Delta Import Export Medical Company — Pharmaceutical Importer Profile (2026) | 3 Products, $362.5K Trade | TransData Nexus

Delta Import Export Medical Company

Pharmaceutical Importer · Vietnam · Antiviral & HIV Medications Focus · $362.5K Total Trade · DGFT Verified

Delta Import Export Medical Company is a pharmaceutical importer based in Vietnam with a total trade value of $362.5K across 3 products in 2 therapeutic categories. Based on 10 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Delta Import Export Medical Company sources from 4 verified Indian suppliers, with Mepro Pharmaceuticals Private Limited accounting for 60.0% of imports.

Delta Import Export Medical Company — Import Portfolio & Supplier Network

Delta Import Export Medical Company import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Delta Import Export Medical Company?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Mepro Pharmaceuticals Private Limited	$208.4K	6	60.0%
Unosource Pharma Limited	$67.8K	5	19.5%
United Biotech Private Limited	$62.5K

What Formulations Does Delta Import Export Medical Company Import?

Formulation	Value	Ships
Pharmaceutical products: valcickeck h2	$50.0K	1
Pharmaceutical products: (valcickeck	$36.8K	1
Pharmaceutical products: valcickeck h2(valsartan 160MG+ hydrochlorothiazide 12.5MG. tabs) visa no.: vn-20012-16	$34.7K	1
Pharmaceutical article / ods / product / item medicine	$34.6K	3
Pharmaceutical products: valcickeck h2(valsartan 160MG+ hydrochlorothiazide 12.5MG. tabs) visa no.: 890110014924	$34.2K	1
Pharmaceutical products: valcickeck h2(valsartan 160MG+ hydrochlorothiazide 12.5MG. tabs USP) visa no.: 890110014924	$34.2K	1
Pharmaceutical products medicine -	$33.2K	2
Thalide 100 capsule ( thalidomide capsules USP 100MG ) batch: tlca5b1 mfg: 18/01/2025 exp	$23.1K	1
Thalide 100 capsule thalidomide capsules USP 100MG batch tlce5b2 mfg 05 25 exp 05	$20.5K	1
Pharmaceutical products: valcickeck	$18.4K	1
Thalide 50 capsule ( thalidomide capsules USP 50MG ) batch: tlca5a2 mfg: 29/01/2025	$11.8K	1
Swazi 500 azithromycin 500MG TAB 1x3t batch no aag10123a mfg 19 02 2023 exp 18 02 2026 packs 19440x1x3 58320	$8.7K	1
Thalide 50 capsule thalidomide capsules USP 50MG batch tlce5a3 mfg 05 25 exp 05	$7.1K	1

Delta Import Export Medical Company imports 13 distinct pharmaceutical formulations. Showing top 13 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Sofosbuvir	Antiviral & HIV Medications	$150.0K	3	0.4%	10
2	Velpatasvir	Antiviral & HIV Medications	$150.0K	3	0.6%	5
3	Thalidomide	Advanced Oncology	$62.5K	4	3.2%	7

Delta Import Export Medical Company imports 3 pharmaceutical products across 2 categories into Vietnam totaling $362.5K.

Delta Import Export Medical Company — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Delta Import Export Medical Company Limited, established on July 7, 2008, is a privately held pharmaceutical importer based in Tu Son City, Bac Ninh Province, Vietnam. The company operates under the business registration number 2300339608 and is registered with the Bac Ninh Province Department of Planning and Investment. Delta Import Export Medical Company specializes in the wholesale distribution of pharmaceutical products, focusing on finished pharmaceutical formulations such as tablets, capsules, syrups, and injections. The company's strategic decisions are guided by key figures TRAN T.H and PHAN T.T.H, ensuring effective leadership and direction.

2Distribution Network

While specific details about Delta Import Export Medical Company's warehouse locations and logistics capabilities are not publicly disclosed, the company's import activities indicate a robust distribution network. The company has engaged in multiple shipments from India, suggesting established logistics channels capable of handling international trade. The primary port of unloading for these shipments is Hai Phong, Vietnam, indicating a strategic use of major ports for efficient distribution within Vietnam.

3Industry Role

Delta Import Export Medical Company plays a significant role in Vietnam's pharmaceutical supply chain as a primary wholesaler. By importing a diverse range of finished pharmaceutical formulations, the company ensures the availability of essential medications across the country. Its focus on high-demand therapeutic areas, such as antiviral and oncology medications, underscores its commitment to addressing critical healthcare needs in Vietnam.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Delta Import Export Medical Company

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Delta Import Export Medical Company's sourcing strategy reveals a high concentration on a select group of suppliers. The company has engaged in 10 shipments from four unique Indian suppliers, with MEPRO Pharmaceuticals Private Limited accounting for 60% of the total import value. This concentration suggests a strategic choice to maintain strong relationships with key suppliers, potentially ensuring favorable terms and consistent product quality. However, such dependency also poses risks; any disruption with these suppliers could significantly impact Delta's supply chain. The shipment data indicates a stable relationship, as evidenced by multiple shipments from these suppliers over the years.

2Supply Chain Resilience

The resilience of Delta Import Export Medical Company's supply chain is closely tied to its reliance on a limited number of suppliers. While this focus may streamline operations and strengthen partnerships, it also exposes the company to potential vulnerabilities. The absence of backup suppliers and limited formulation diversity could pose challenges in the event of supply disruptions. Additionally, the company's exposure to specific shipping routes, such as Hai Phong, could be a risk factor if these routes face operational issues. Ensuring regulatory compliance among key suppliers is crucial to maintain uninterrupted supply and adhere to Vietnam's stringent pharmaceutical import regulations.

Importing Pharmaceuticals into Vietnam — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Vietnam

1Regulatory Authority & Framework

In Vietnam, the pharmaceutical industry is regulated by the Ministry of Health (MOH), which oversees the import, distribution, and sale of pharmaceutical products. The Law on Pharmacy 2016 provides the legal framework for pharmaceutical activities, including import regulations. Decree No. 54/2017/ND-CP, amended by Decree No. 88/2023/ND-CP, outlines specific provisions for the import of medicines and medicinal ingredients, emphasizing the need for compliance with safety and quality standards.

2Import Licensing & GMP

To import pharmaceutical products into Vietnam, companies must obtain an import license from the MOH, as stipulated by the Law on Pharmacy 2016. This license is granted based on compliance with Good Manufacturing Practice (GMP) standards. Vietnam recognizes GMP certificates from the European Union (EU GMP), World Health Organization (WHO GMP), and Pharmaceutical Inspection Co-operation Scheme (PIC/S), facilitating international trade and ensuring product quality.

3Quality & Labeling

Delta Import Export Medical Company — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Delta Import Export Medical Company's focus on antiviral and oncology medications aligns with the growing demand for treatments in these therapeutic areas in Vietnam. The import of Sofosbuvir and Velpatasvir addresses the need for effective hepatitis C treatments, while Thalidomide caters to oncology patients. This strategic product selection demonstrates the company's commitment to providing essential medications that meet critical healthcare needs.

2Sourcing Profile

Delta Import Export Medical Company's sourcing strategy emphasizes the import of generic drugs, particularly in the antiviral and oncology categories. The company's preference for finished pharmaceutical formulations ensures that products are ready for distribution upon arrival, streamlining the supply chain. India's established pharmaceutical manufacturing capabilities and adherence to international quality standards make it a suitable partner for Delta's procurement needs.

3Market Positioning

Based on its product mix, Delta Import Export Medical Company primarily serves the wholesale distribution segment of the Vietnamese pharmaceutical market. By importing essential medications and ensuring their availability across the country, the company plays a pivotal role in supplying both retail pharmacies and hospitals, thereby contributing to the overall healthcare infrastructure.

Seller's Guide — How to Become a Supplier to Delta Import Export Medical Company

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Delta Import Export Medical Company by offering alternative products or formulations that the company currently does not import. This could help diversify Delta's supplier base and reduce dependency on a limited number of suppliers. Additionally, Indian exporters can explore opportunities to supply products in therapeutic areas that are in high demand in Vietnam, thereby meeting the evolving healthcare needs of the market.

2Requirements & Qualifications

Indian exporters seeking to supply Delta Import Export Medical Company must ensure that their products comply with Vietnam's pharmaceutical import regulations, including obtaining GMP certifications recognized by the MOH. Products must undergo batch testing and meet stability requirements. Labeling must be in Vietnamese, providing clear information for both patients and healthcare professionals. Additionally, exporters should be prepared to navigate the import licensing process, which requires adherence to the Law on Pharmacy 2016 and related decrees.

3How to Approach

Frequently Asked Questions — Delta Import Export Medical Company

What products does Delta Import Export Medical Company import from India?

Delta Import Export Medical Company imports 3 pharmaceutical products across 2 categories. Top imports: Sofosbuvir ($150.0K), Velpatasvir ($150.0K), Thalidomide ($62.5K).

Who supplies pharmaceuticals to Delta Import Export Medical Company from India?

Delta Import Export Medical Company sources from 4 verified Indian suppliers. The primary supplier is Mepro Pharmaceuticals Private Limited (60.0% of imports, $208.4K).

What is Delta Import Export Medical Company's total pharmaceutical import value?

Delta Import Export Medical Company's total pharmaceutical import value from India is $362.5K, based on 10 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Delta Import Export Medical Company focus on?

Delta Import Export Medical Company imports across 2 categories. The largest: Antiviral & HIV Medications (82.8%), Advanced Oncology (17.2%).

Get Full Delta Import Export Medical Company Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.